Early In Vivo Experience With Tissue-Engineered Trileaflet Heart Valves
暂无分享,去创建一个
Frederick J. Schoen | Joseph P. Vacanti | Simon P. Hoerstrup | John E. Mayer | Ralf Sodian | David P. Martin | J. Mayer | J. Vacanti | R. Sodian | S. Hoerstrup | F. Schoen | S. Daebritz | A. Moran | J. Sperling | B. S. Kim | Jason S. Sperling | Sabine Daebritz | Adrian M. Moran | Byung S. Kim | B. Kim
[1] R Langer,et al. Fabricating tubular devices from polymers of lactic and glycolic Acid for tissue engineering. , 1995, Tissue engineering.
[2] W G Henderson,et al. A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis. Veterans Affairs Cooperative Study on Valvular Heart Disease. , 1993, The New England journal of medicine.
[3] C K Breuer,et al. The in vitro construction of a tissue engineered bioprosthetic heart valve. , 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[4] N. Ratliff,et al. Evidence for rejection of homograft cardiac valves in infants. , 1998, The Journal of thoracic and cardiovascular surgery.
[5] F J Schoen,et al. Founder's Award, 25th Annual Meeting of the Society for Biomaterials, perspectives. Providence, RI, April 28-May 2, 1999. Tissue heart valves: current challenges and future research perspectives. , 1999, Journal of biomedical materials research.
[6] Robert Langer,et al. Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation , 1999, The Lancet.
[7] F. R. Rosendaal,et al. Thromboembolic and Bleeding Complications in Patients With Mechanical Heart Valve Prostheses , 1994, Circulation.
[8] I. Bergman,et al. Two Improved and Simplified Methods for the Spectrophotometric Determination of Hydroxyproline. , 1963 .
[9] W. E. Jamieson,et al. Modern Cardiac Valve Devices— Bioprostheses and Mechanical Prostheses: State of the Art , 1993, Journal of cardiac surgery.
[10] C K Breuer,et al. Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model. , 1996, Circulation.
[11] Richard A. Lange,et al. Prosthetic heart valves. , 1996, The New England journal of medicine.
[12] F J Schoen,et al. Pathological considerations in replacement cardiac valves. , 1992, Cardiovascular pathology.
[13] J E Mayer,et al. Tissue engineering of a trileaflet heart valve-early in vitro experiences with a combined polymer. , 1999, Tissue engineering.
[14] R Langer,et al. Functional arteries grown in vitro. , 1999, Science.
[15] C K Breuer,et al. Tissue engineering lamb heart valve leaflets , 1996, Biotechnology and bioengineering.
[16] D. Kültz,et al. Hyperosmolality Causes Growth Arrest of Murine Kidney Cells , 1998, The Journal of Biological Chemistry.
[17] R Langer,et al. Tissue-engineered heart valve leaflets: does cell origin affect outcome? , 1997, Circulation.
[18] R. Mitchell,et al. Pathological considerations in cryopreserved allograft heart valves. , 1995, The Journal of heart valve disease.
[19] M. Cowan,et al. American Heart Association. , 2018, P & T : a peer-reviewed journal for formulary management.
[20] D C Naftel,et al. Long-term function of cryopreserved aortic homografts. A ten-year study. , 1993, The Journal of thoracic and cardiovascular surgery.
[21] O. Peoples,et al. Biodegradable plastics from plants , 1996 .
[22] David P. Martin,et al. Fabrication of a trileaflet heart valve scaffold from a polyhydroxyalkanoate biopolyester for use in tissue engineering. , 2000, Tissue engineering.
[23] David J. Mooney,et al. Tissue engineering using cells and synthetic polymers , 1993 .